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Background/Aims: Vitamin D may have a protective role in the develop-
ment of many chronic diseases, including T2DM. The aim of this study was
to investigate the association between serum 25OHD, the risk of T2DM and
presence of the metabolic syndrome (MetS).
Methods: We analysed the 2009-2010 Victorian Health Monitor survey
where information on 25OHD, HBA1c, fasting plasma glucose and pres-
ence of the metabolic syndrome were available. Logistic regression ana-
lyses were used to evaluate the association between tertiles of serum
25OHD and HbA1c (< 5.7% vs. 5.7%), fasting plasma glucose (< 5.6 mmol/
L vs.  5.6 mmol/L) and MetS (yes/no). Confounders tested were age,
gender, country of birth, income, education, physical activity, smoking
status, season, weight, calcium, magnesium, energy intake, television
viewing time, sitting time, waist circumference, BMI, and intakes of
alcohol, total fat, carbohydrate, protein, retinol, ﬁbre and caffeine.
Results: A total of 3434 Australian adults excluding those with T1DM and
T2DM entered the analysis. Greater 25OHD had a lower OR of being
associated with the presence of MetS [OR 0.36 (95% CI; 0.27, 0.48), p ¼
0.005], lower OR of a higher HbA1c [OR 0.62 (95% CI; 0.49, 0.77), p ¼
0.004], and a lower OR of higher fasting plasma glucose [OR 0.55 (95% CI;
0.39, 0.77), p ¼ 0.004].
Conclusions: Higher 25OHD may have a beneﬁcial effect on MetS and risk
of T2DM.
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Background/Aims: Vitamin D has anti-proliferative, pro-differentiative
and immune-modulating effects. We aimed to determine whether raising
serum 25(OH)D through vitamin D3 supplementation improves psoriasis.
Methods: In a randomised (2:1), double-blind, placebo-controlled trial,
101 participants > 18 y with plaque psoriasis took 200,000 International
Units (IU) of cholecalciferol at baseline then 100,000 IU/month for 11
months (n ¼ 67), or placebo (n ¼ 34). Psoriasis Area and Severity Index
(PASI) and serum 25(OH)D concentration were assessed at baseline, 3m,
6m, 9m and 12m. Primary outcomes were a) difference in PASI between
groups over time, and b) the relationship between PASI and 25(OH)D over
time, assessed by linear mixed models adjusted for confounding and/or
individual factors.
Results: There was a signiﬁcant inverse relation-ship between 25(OH)D
and PASI. Elevating serum 25(OH)D by increments from 25 e 125nmol/L
was associated with mild decreases in PASI (estimated range of decrease
0 e 2.6; p ¼ 0.002). PASI did not differ by group (p ¼ 0.62, group*time p ¼
0.54), and an improvement in PASI of 50% or higher was achieved by 11.9%
of treatment and 11.8% of placebo. However, mean 25(OH)D signiﬁcantly
increased from baseline at 3m for treatment [b¼ 33 (95% CI 28e 38) nmol/
L, p< 0.001] and 6m for placebo [b¼ 24 (95% CI 17e 30) nmol/L, p < 0.001],
possibly confounding these results.
Conclusions: At a population level, elevating serum 25(OH)D is associated
with improved psoriasis. Estimated improvements were mild at 25(OH)D
concentrations in this study and may not be clinically signiﬁcant; higher
concentrations could have greater beneﬁt.
Funding source(s): Lottery Health Research, Massey University.
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Background/Aims: In contrast to some epidemiological evidence our
previous research found that a 4-week diet high in dairy reduced insulin
sensitivity compared to one high in red meat. Our aim was to investigate
whether a dairy meal produced lower glucose compared with a carbohy-
drate-matched red meat meal.
Methods: A total of 19 men and 24 women (age 50.8 ± 16.0, BMI 30.0 ± 3.5
kg/m2) completed the randomized crossover study. Twenty-two partici-
pants had normal glucose tolerance; 21 had impaired fasting glucose and/
or impaired glucose tolerance. One meal contained lean red meat, bread
and orange juice and the other milk, yoghurt, cheese and bread. Meals
were isoenergetic, equal in macronutrient proﬁle and consumed one week
apart. Glucose and insulin were measured before and 30, 60, 90, 120, 150
and 180 minutes after consuming the meal. Difference between meals was
tested using repeated measures ANOVA and paired sample T-tests.
Results: The red meat meal resulted in a higher glucose response at T30 (p
< 0.001) however total glucose AUC was not different between meals (p ¼
NS). Incremental AUC for glucose was signiﬁcantly higher after the dairy
meal (2.23 ± 3.19 mmol/L vs. 0.88 ± 3.73 mmol/L, p ¼ 0.004). Total and
incremental insulin AUC was not different between meals (iAUC 159.65
mU/L for red meat, vs. 167.49 mU/L for dairy, p ¼ NS).
Conclusions: Lean red meat and dairy meals produced a similar glycemic
response. The higher glucose response 30 minutes after the red meat meal
is likely attributable to differences in glycemic load between orange juice
and milk or yoghurt. An insulinotropic effect of dairy was not observed.
Funding source(s): University of South Australia.
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Background/Aims: Inﬂammation of the mammary gland (mastitis) caused
by invading pathogens is common among lactating dairy cows and causes
great economic losses. We recently demonstrated that Chinese propolis
(CP), a resinous substance collected by honeybees, can positively inﬂuence
anti-inﬂammatory processes and antioxidant defense systems in vivo but
little is known about how propolis treatment of mastitis in dairy cows may
inﬂuence these activities.
Methods: We investigated the potentially protective effects of CP on as-
pects of mastitis by using an in vitromodel of mastitis-induced cell damage
involving cultured bovine mammary epithelial cells (MAC-T) which
received a range of mastitis pathogen-related insults. Cell viability was
measured by cell counting kit (CCK)-8 cell viability assay and expression of
inﬂammatory or antioxidant genes were measured by qPCR. Using a cell-
based reporter assay system, we evaluated CP and its main constituents’ on
NF-kB and Nrf2-ARE transcription activity.
Results: Treatment of cells with cell wall components lipopolysaccharide
(LPS), heat inactivated E. coli and S. aureus, but not TNF-a or lipo-teichoic
acid (LTA), signiﬁcantly decreased cell viability (p < 0.01). CP pretreatment
(15 mg/mL) signiﬁcantly (p < 0.05) protected cell viability losses. CP pre-
treatment of MAC-T cells resulted in less impact on IL-6 and TNF-a mRNA
expressions but increased expression of antioxidant genes HO-1, Txnrd-1
and GCLM. CP and its polyphenolic active components (mainly CAPE and
quercetin) had strong inhibitive effects against NF-kB and increased the
transcriptional activation of the Nrf2-ARE pathway.
Conclusions: Our ﬁndings support the usage of dietary propolis for the
treatment of bovine mastitis.
Funding source(s): National Science Foundation of China.
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Background/Aims: An accurate non-invasive method is required to mea-
sure body composition of infants. Ultrasound (US) and bioelectrical
impedance analysis (BIA) are inexpensive methods that could fulﬁl this
need in predicting percentage fat mass (%FM). Both have been well vali-
dated in adults and children but not in infants. This study compared these
methods with reference to international normative data.
Methods: %FM was calculated from whole-body BIA and US skin-fold (SF)
measurements (biceps, triceps, subscapular, suprailiac) of 2, 5, 9 and 12 m-
old healthy, breast-fed term infants (n ¼ 44). %FM values were determined
using 6 age-appropriate BIA equations and 3 US-derived SF equations. Data
were analysed using ANOVA and probability analysis.
Results: %FM was signiﬁcantly (p < 0.001) lower at 2 than at 5, 9, or 12
months of age irrespective of measurement method. Overall predictions
based on US were not signiﬁcantly different from BIA-based predictors (p
¼ 0.076) but there were signiﬁcant differences between individual pre-
dictions. No predictor equation, US or BIA, performed well at 2 m, with <
30% of predicted values falling within the 95% conﬁdence range for the
reference data. At 5, 9, 12 m, BIA-based predictors performed better than
US-based predictors but with most predicting only between 40 and 68% of
subjects within the 95% conﬁdence reference range compared to 0 to 50%
for US predictors.
Conclusions: Simple techniques for the assessment of body composition
do not predict accurately percentage body fat in infants under 1 year of age
when compared with reference data.
Funding source(s): Australian Postgraduate Award, Medela AG (Switzer-
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Background/Aims: The Children's Hospital at Westmead (Sydney Chil-
dren’s Hospitals Network), is a tertiary paediatric hospital with 312 inpa-
tient beds. The Food Service Department operates a cook fresh food
production system using 3 plating lines a day. There are more than 85
special diets. A series of incidents in 2014 involving a patient diagnosed
with anaphylaxis to multiple food allergens required formal investigation
of risks from food to clinical management and inpatient safety. One inci-
dent resulted in harm to the individual requiring a ﬁve hour admission to
the paediatric intensive care unit. In two incidents a “special” nurse was
bedside however, despite training in anaphylaxis management, neither
nurse appeared to recognise the risk to the patient presented by food.
Methods: Ingredient compliance with diet codes, the range of diet codes,
meal ordering, food production, plating and distribution procedures were
examined and mapped generating signiﬁcant changes across the system.
Communication methods were also reviewed.
Results: The two consequent investigations of these incidents identiﬁed
multiple points of risk throughout the food production process. The diets
at greatest risk were those requiring strict accuracy of content with min-
imal tolerance for error. These included multiple allergy diets, some
metabolic diets and the ketogenic diet.
Conclusions: There are multiple points of risk to inpatient safety along a
streamlined food provision pathway in a hospital. Signiﬁcant changes have
been made to mitigate risk at various points however 100% risk free is not
achievable. Heightened awareness of all concerned appears to be key.
Funding source(s): N/A.
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Background/Aims: Flavonoids such as naringenin and naringin are sug-
gested to affect lipid metabolism by modulating the activity of D6 and D5
fatty acid desaturases and other key genes and enzymes. Consequently, the
biosynthesis of n-3 LC-PUFA from ALA is likely to be modulated in the
presence of ﬂavonoids.
Aim: To investigate the effect of naringenin and naringin on n-3 LC-PUFA
biosynthesis from ALA in hepatocytes.
Methods: FaO hepatocytes were seeded in 30 small ﬂasks then incubated
for 5 days with or without 100 mM ALA (3 ﬂasks each) with no added
ﬂavonoids. Other ﬂasks received 100 mM ALA in addition to either nar-
ingenin (6 ﬂasks, 50 mg/mL of culture medium) or naringin (6 ﬂasks, 20 mg/
mL of culture medium). Also, 6 ﬂasks received naringenin and 6 other
ﬂasks received naringin but without adding ALA. Two-way ANOVA tested
the differences and interaction between groups.
Results: EPA content was marginally but signiﬁcantly enhanced in hepa-
tocytes incubated with naringenin and ALA (1.0 ± 0.1 mg/mg of cells) and
naringin with ALA (0.9 ± 0.1 mg/mg of cells). Flavonoids without ALA did
not change EPA content in the cells. Also, the ﬂavonoids did not signiﬁ-
cantly improve DPA or DHA content in the cells regardless of ALA
supplementation.
Conclusions: Naringin and naringenin, ﬂavonoids from citrus peel, have a
potential in improving n-3 LC-PUFA biosynthesis from ALA in hepatocytes
in vitro. Further studies can conﬁrm this effect in vivo and provide an
insight into functional foods interaction with fatty acid metabolism.
Funding source(s): N/A.
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Background/Aims: Extract optimisation not only results in a greater yield,
but allows accurate quantitation of the compound and comparison be-
tween different cultivars of a species. While optimisation of anthocyanin
extract has been described for a variety of fruits, extraction from the whole
fruit of sweet cherries has not been comprehensively investigated. Our
primary aimwas to determine the optimal parameters for the extraction of
anthocyanins from sweet cherries e speciﬁcally temperature and time of
extraction, solvent to solid ratio, solvent type and solvent concentration.
Methods: Extractions with one or two independent variables were con-
ducted using the edible portion of Prunus avium ‘Lapins’ cherries. The
optimal condition for each parameter was based on total anthocyanin
content (TAC), and was used for all subsequent optimisation experiments.
TAC was calculated by summation of UPLC-derived peak areas, expressed
as mg of cyanidin-3-glucoside equivalents per 100g fresh weights (mg/100
g fresh weight).
Results: Extraction for 90 minutes at 37oC, using 100% acidiﬁed ethanol at
a solvent to solid ratio of 10mL/g, resulted in the highest TAC (243.5 mg/
100 g fresh weight).
Conclusions: The TAC of ‘Lapins’ cherries determined using the optimised
protocol is more than twice that previously reported. Results from our
study contradict previous anthocyanin extraction research, which advo-
cates the use of either low temperature or short, high temperature ex-
tractions to maximise yield. The novel ﬁnding that extraction at
physiological temperature results in the highest TAC is of signiﬁcance
when considering translation to in vivo applications.
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